Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.47 |
| ▸ | CAD | P27708 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PPID | Q08752 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4629355 | 0.86 | L3MBTL1 (0.59) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL3870882 | 0.86 | L3MBTL1 (0.79) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL22111187 | 0.86 | L3MBTL1 (0.79) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL4629356 | 0.86 | L3MBTL1 (0.59) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL4629331 | 0.86 | L3MBTL1 (0.79) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL31228993 | 0.80 | L3MBTL1 (0.60) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL23849249 | 0.78 | CYP1A2 (0.58) | L3MBTL1KMT2APOLBNOD1KDM4E | |
| SCHEMBL25512946 | 0.77 | L3MBTL1 (0.47) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL30420085 | 0.77 | L3MBTL1 (0.47) | L3MBTL1KMT2APOLBNOD1CAD | |
| SCHEMBL29543223 | 0.77 | L3MBTL1 (0.47) | L3MBTL1KMT2APOLBNOD1CAD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230151034-A1 | PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | COCRYSTAL PHARMA, INC. | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151034-A1 | PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | ASNS, GLUL, GNMT | L3MBTL1 397/4885KMT2A 2657/4885POLB 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.